|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 成人、儿童及孕妇特发性血小板减少性紫癜诊治指南显示文摘特发性血小板减少性紫癜(ITP)是一种自体免疫性疾病,以持续性血小板减少为特征(血小板<150×109/L).其发病机理是自身抗体与血小板抗原结合导致它们在未成熟时即被网状内皮系统,特别是在脾脏中被破坏引起血小板减少. | Provan D Newland A Norfolk D Bolton-Maggs P Lilleyman J Greer I May A Murphy M Ouwehand W Watson S 李振宇 徐开林 | 2004 | 国外医学(输血及血液学分册)2004，27，4： | 25 |
| 2 | 原发性免疫性血小板减少症的研究和诊治:国际共识报告显示文摘1 前言
原发性免疫性血小板减少症(Primary immune thrombocytopenia,ITP)是一种以血小板减少为特点的获得性免疫紊乱.其定义为外周血血小板数量<100×10^9/L,起病隐匿并缺乏明确的病因.一直以来,ITP的缩写表示特发性血小板减少性紫癜(idiopathic thrombocytopenic purpura),但目前认识到该病具有免疫介导的特点,并且大部分病例无出血或仅有少量出血,因此对该术语进行了修正. | Provan D Stasi R Nezoland AC(et al.) 陈飞燕(节译) 梁妤婷(节译) 吴倩倩(节译) 王舒茵(节译) 魏晓星(节译) 叶铁真(审校) | 2010 | 国际输血及血液学杂志2010，33，5： | 4 |
| 3 | International consensus report on the investigation and management of primary immune thrombocytopenia显示文摘 | Provan D Stasi R Newland AC | 2010 | Blood2010，115，2： | 1 |
| 4 | Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial 显示文摘 | Bussel JB Provan D Shamsi T | 2009 | Lancet2009，373，9664： | 1 |
| 5 | International consensus report on the investigation and management of primaryimmune thrombocytopenial显示文摘 | Provan D Stasi R Newland AC | 2010 | Blood2010，115，2： | 1 |
| 6 | International consensus report on the investigation and management of primary immune thrombocytopenia显示文摘 | Provan D Stasi R Newland AC | 2010 | Blood2010，115，2： | 1 |
| 7 | International consensus report on the investigation and management of primary immune thromboeytopenia 显示文摘 | Provan D Stasi R Newland AC | 2010 | Blood2010，115，2： | 1 |
| 8 | International consensus report on the investigation and management of primary immune thrombocytopenia显示文摘 | Provan D Stasi R Newland AC | 2010 | Blood2010，115，2： | 1 |
| 9 | International consensus report on the investigation and management of primary immune thrombocytopenia显示文摘 | Provan D Stasi R Newland AC | 2010 | Blood2010，1，14： | 1 |
| 10 | International consensus report on the investigation and management of primary immune thrombocytopenia 显示文摘 | Provan D Stasi R Newland AC | 2010 | Blood2010，115，2： | 1 |
| 11 | Recent progress in un-derstanding the pathogenesis of immune thrombocytopenia 显示文摘 | Semple JW Provan D Garvey MB | 2010 | Curr Opin Hematol2010，17，6： | 1 |
| 12 | Internationalconsensus report on the investigation and management of primaryimmune thrombocytopenia显示文摘 | Provan D Stasi R Newland A C ef al | 2010 | Blood2010，115，2： | 1 |
| 13 | Effect of a phytoestrogen food supplement on reproductive health in normal males显示文摘 | Mitchell JH Cawood E Kinniburgh D Provan A Collins AR Irvine DS | 2001 | Clin Sci2001，100，： | 1 |
| 14 | International consensus report on the investigation and management of primary immune thromboeyto penia显示文摘 | Provan D Stasi R New land AC | 2010 | Blood2010，115，： | 1 |
| 15 | International consensus re-port on the investigation and management of primary immunethrombocytopenia显示文摘 | Provan D Stasi R Newland A C | 2010 | Blood2010，115，2： | 1 |
| 16 | Inter-national consensus report on the investigation andmanagement of primary immune thrombocytopenia显示文摘 | PROVAN D’STASI R NEWLAND A C | 2010 | Blood2010，115，： | 1 |
| 17 | International consensus report on the investigation and management of primary immune thrombocytopenia 显示文摘 | PROVAN D STASI R NEWLAND A C | 2010 | Blood2010，115，： | 1 |
| 18 | International consensus report on the investigation and management of primary immune thrombocytopenia 显示文摘 | Provan D Stasi R Newland AC | 2010 | Blood2010，115，2： | 1 |
| 19 | International consensus report on the investigation and management of primary immune thrombocytopenia 显示文摘 | Provan D Stasi R Newland AC | 2010 | Blood2010，115，2： | 1 |
| 20 | Better blood transtusion 显示文摘 | Provan D | 1999 | BMJ1999，318，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员